Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes
Influential guidelines have supported the role of metformin in the management of polycystic ovary syndrome (PCOS) for a number of years. However, regulatory approvals for this therapeutic indication are still exceptional and exist only in a few countries, including for the originator, Glucophage®. P...
Saved in:
Main Authors: | Kerstin MG Brand, Ulrike Gottwald-Hostalek, Aimee Andag-Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Women's Health |
Online Access: | https://doi.org/10.1177/17455057241311759 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
by: Pascal Froment, et al.
Published: (2006-01-01) -
Pathophysiologic Mechanisms of Insulin Secretion and Signaling-Related Genes in Etiology of Polycystic Ovary Syndrome
by: Zahra Shaaban, et al.
Published: (2021-01-01) -
Therapeutic efficacy and mechanism of artesunate for mouse model of polycystic ovary syndrome
by: WANG Xueling, et al.
Published: (2025-02-01) -
Correlation of Endometrial Glycodelin Expression and Pregnancy Outcome in Cases with Polycystic Ovary Syndrome Treated with Clomiphene Citrate Plus Metformin: A Controlled Study
by: Selda Uysal, et al.
Published: (2015-01-01) -
Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome
by: Susanne Tan, et al.
Published: (2015-01-01)